| Page 1145 | Kisaco Research

Interview: Jeanette Leusen, Head of the Immunotherapy Group and UMAB, UMCU

Model Risk Management for the Machine Learning Era

Stealth Licensing

Collaborative standardisation and disruptive innovation: summary paper developed by Haris Tsilikas, Max Plank Institute, for 4iP Council.

Why researchers need an IP strategy

Nicholas New

CEO

Optalysys

Yael Alter

Chief Executive Officer

NR Soos Technology

Dr Eve Hanks

Chief Executive Officer & Founder

MI:RNA Diagnostics

Eleanor Wheeler

Associate Director of Research & Policy

The Health Policy Partnership

Bruce Batten PhD

Founder

GRIP Molecular